Exploring Tumor Biology with Fluorodeoxyglucose–Positron Emission Tomography Imaging in Breast Carcinoma
Authors:
- 31 October 2009
- journal article
- review article
- Published by Elsevier in PET Clinics
- Vol. 4 (4) , 381-389
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parametersCancer, 2007
- Implications of Standardized Uptake Value Measurements of the Primary Lesions in Proven Cases of Breast Carcinoma with Different Degree of Disease Burden at Diagnosis: Does 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography Predict Tumor Biology?Molecular Imaging and Biology, 2007
- The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on 18F-FDG Uptake of Primary Breast Cancer LesionsJournal of Nuclear Medicine, 2007
- The relationship between FDG uptake in PET scans and biological behavior in breast cancerBreast Cancer, 2007
- FDG uptake in breast cancer: correlation with biological and clinical prognostic parametersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Expression of hexokinase II and Glut-1 in untreated human breast cancerNuclear Medicine and Biology, 2002
- Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission TomographyJournal of Clinical Oncology, 2002
- Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and LimitationsJournal of Clinical Oncology, 2000
- Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Role for glucose transporter 1 protein in human breast cancerPathology and Oncology Research, 1998